Berlin
Germany
44
2024-12-12
The entities that hold a legal rights for patent applications filed by inventor Kaufmann Jorg:
Jorg Kaufmann from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
PREPARATION FOR USE IN A METHOD FOR THE TREATMENT AND/OR PREVENTION OF A DISEASE
#2 | 2023-08-24Lipid Composition and Use Thereof for Delivery of a Therapeutically Active Agent to Endothelium
#3 | 2021-08-26RECOMBINANT NUCLEIC ACID CONSTRUCT
#4 | 2021-03-04Interfering RNA molecules
#5 | 2019-12-26Interfering RNA molecules
#6 | 2019-02-07MEANS FOR LUNG SPECIFIC DELIVERY
#7 | 2019-01-24Interfering RNA molecules
#8 | 2018-10-11Interfering RNA molecules
#9 | 2018-08-09Interfering RNA molecules
#10 | 2017-10-19LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM
#11 | 2017-08-31Interfering RNA molecules
#12 | 2017-08-31Interfering RNA molecules
#13 | 2017-08-31Interfering RNA molecules
#14 | 2017-08-31Interfering RNA molecules
#15 | 2017-02-09LIPIDS, LIPID COMPLEXES AND USE THEREOF
#16 | 2016-05-12Interfering RNA molecules
#17 | 2015-12-17Lipids, lipid complexes and use thereof
#18 | 2015-11-26FURTHER USE OF PROTEIN KINASE N BETA
#19 | 2015-04-16Interfering RNA molecules
#20 | 2015-01-29Coated lipid complexes and their use
#21 | 2014-11-06Lipids, lipid complexes and use thereof
#22 | 2014-11-06Means for inhibiting the expression of ANG2
#23 | 2014-09-04MEANS FOR INHIBITING THE EXPRESSION OF ORC-1
#24 | 2013-06-27Lipids, lipid complexes and use thereof
#25 | 2013-04-25Interfering RNA molecules
#26 | 2013-04-18Therapeutic uses of inhibitors of RTP801
#27 | 2012-07-05Further use of protein kinase N beta
#28 | 2012-03-15Lipids, lipid complexes and use thereof
#29 | 2012-01-26Means for inhibiting the expression of ANG2
#30 | 2011-12-01LIPIDS, LIPID COMPLEXES AND USE THEREOF
#31 | 2011-09-08Means for inhibiting the expression of Orc-1
#32 | 2011-05-19Interfering RNA molecules
#33 | 2011-05-19Therapeutic uses of inhibitors of RTP801
#34 | 2011-02-03Methods of treating eye diseases in diabetic patients
#35 | 2011-01-13Further Use of Protein Kinase N Beta
#36 | 2010-05-11Further use of protein kinase N beta
#37 | 2010-03-11Coated lipid complexes and their use
#38 | 2009-12-10Means for inhibiting the expression of protein kinase 3
#39 | 2009-10-08MEANS FOR INHIBITING THE EXPRESSION OF CD31
#40 | 2009-07-23Interfering RNA molecules
#41 | 2009-03-19LIPOPLEX FORMULATIONS FOR SPECIFIC DELIVERY TO VASCULAR ENDOTHELIUM
#42 | 2008-11-18Interfering RNA molecules
#43 | 2008-11-06Lipids, lipid complexes and use thereof
#44 | 2006-09-28Therapeutic uses of inhibitors of RTP801
196729 ⎘